Device typeCD61 platelet glycoprotein IIIa marker IVD, antibody: One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of CD61 platelet glycoprotein IIIa marker in a clinical specimen.
FDA categoryReagents, specific, analyte
Device ID05700572024774
MRI safetyLabeling does not contain MRI Safety Information
Total Volume1 Milliliter